BioCentury | Sep 8, 2020
Management Tracks

Black Diamond names Humphrey CMO; plus Edmondson to lead chemistry at Nimbus, Recce, Amarna and more

...SVP of investor relations and corporate strategy. Nomura was a senior analyst covering biotechnology at Mizuho Securities.Skin...
BioCentury | Jun 17, 2020
Finance

Crossovers pile into new rounds for C4, 4D Molecular

...Capital Life Sciences, Commodore Capital, 3E Bioventures Capital, HBM Healthcare Investments, Lightchain Capital, Logos Capital, Mizuho Securities...
BioCentury | Jan 3, 2020
Clinical News

As itacitinib stumbles in acute GvHD, Incyte turns to chronic setting

...on whether itacitinib can succeed in the chronic setting, which holds a larger market opportunity. Mizuho Securities...
BioCentury | Jul 23, 2019
Financial News

Frequency raises $62M to fund Phase II of hearing loss therapy

...areas such as multiple sclerosis with its platform. New investors Deerfield Management, RTW Investments and Mizuho Securities...
BioCentury | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

...diseases. Barry Shin has joined Trevena Inc. (NASDAQ:TRVN) as CFO. He was managing director in Mizuho Securities’...
BioCentury | May 25, 2019
Financial News

New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero

...in an IPO underwritten by J.P. Morgan, Goldman Sachs, Jefferies, SVP Leerink, KKR, Piper Jaffray, Mizuho Securities...
BioCentury | Jan 25, 2019
Financial News

UroGen, Wave each raise $150M follow-ons

...shares were off $5.98 (14%) to $35.73 on Jan. 24. Underwriters were Jefferies, SVB Leerink, Mizuho Securities...
BioCentury | Jan 24, 2019
Financial News

UroGen, Wave each raise $150M follow-ons

...its shares were off $5.98 (14%) to $35.73 on Thursday. Underwriters were Jefferies, SVB Leerink, Mizuho Securities...
BioCentury | Jul 13, 2018
Financial News

Assembly raises $144M follow-on

...of 4 million shares at $36 in a follow-on underwritten by Jefferies, Leerink, William Blair, Mizuho Securities...
BioCentury | Jul 12, 2018
Financial News

Assembly raises $144M follow-on

...of 4 million shares at $36 in a follow-on underwritten by Jefferies, Leerink, William Blair, Mizuho Securities...
Items per page:
1 - 10 of 38
BioCentury | Sep 8, 2020
Management Tracks

Black Diamond names Humphrey CMO; plus Edmondson to lead chemistry at Nimbus, Recce, Amarna and more

...SVP of investor relations and corporate strategy. Nomura was a senior analyst covering biotechnology at Mizuho Securities.Skin...
BioCentury | Jun 17, 2020
Finance

Crossovers pile into new rounds for C4, 4D Molecular

...Capital Life Sciences, Commodore Capital, 3E Bioventures Capital, HBM Healthcare Investments, Lightchain Capital, Logos Capital, Mizuho Securities...
BioCentury | Jan 3, 2020
Clinical News

As itacitinib stumbles in acute GvHD, Incyte turns to chronic setting

...on whether itacitinib can succeed in the chronic setting, which holds a larger market opportunity. Mizuho Securities...
BioCentury | Jul 23, 2019
Financial News

Frequency raises $62M to fund Phase II of hearing loss therapy

...areas such as multiple sclerosis with its platform. New investors Deerfield Management, RTW Investments and Mizuho Securities...
BioCentury | Jun 28, 2019
Company News

Management tracks: Gottlieb joins Pfizer board; plus Adaptimmune, Xencor, Arcus and more

...diseases. Barry Shin has joined Trevena Inc. (NASDAQ:TRVN) as CFO. He was managing director in Mizuho Securities’...
BioCentury | May 25, 2019
Financial News

New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero

...in an IPO underwritten by J.P. Morgan, Goldman Sachs, Jefferies, SVP Leerink, KKR, Piper Jaffray, Mizuho Securities...
BioCentury | Jan 25, 2019
Financial News

UroGen, Wave each raise $150M follow-ons

...shares were off $5.98 (14%) to $35.73 on Jan. 24. Underwriters were Jefferies, SVB Leerink, Mizuho Securities...
BioCentury | Jan 24, 2019
Financial News

UroGen, Wave each raise $150M follow-ons

...its shares were off $5.98 (14%) to $35.73 on Thursday. Underwriters were Jefferies, SVB Leerink, Mizuho Securities...
BioCentury | Jul 13, 2018
Financial News

Assembly raises $144M follow-on

...of 4 million shares at $36 in a follow-on underwritten by Jefferies, Leerink, William Blair, Mizuho Securities...
BioCentury | Jul 12, 2018
Financial News

Assembly raises $144M follow-on

...of 4 million shares at $36 in a follow-on underwritten by Jefferies, Leerink, William Blair, Mizuho Securities...
Items per page:
1 - 10 of 38